Organovo to Present on December 14 in a Live Interactive Webcast at VirtualInvestorConferences.com

SAN DIEGO, Dec. 7, 2016

For investors who are not yet familiar with the Company, an informational video and investor presentation is available on Organovo's website:  http://www.organovo.com/     

Date: Wednesday, December 14, 2016
Time: 1:00 p.m. ET/10:00 a.m. PT
Link: http://tinyurl.com/1214prepr

It is recommended that investors pre-register to save time and receive event updates.  This will be a live, interactive online event where investors are invited to ask the company questions in real-time, both in the presentation hall as well as the association's "virtual trade booth."  If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

Learn more about the event at www.VirtualInvestorConferences.com.

About Organovo Holdings Inc.

Organovo designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications.  The Company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic and other partners.  Organovo's 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost.  The Company's ExVive Human Liver and Kidney Tissues are used in toxicology and other preclinical drug testing.  The Company also actively conducts early research on specific tissues for therapeutic use in direct surgical applications.  In addition to numerous scientific publications, the Company's technology has been featured in The Wall Street Journal, Time Magazine, The Economist, Forbes, and numerous other media outlets.  Organovo is changing the shape of life science research and transforming medical care.  Learn more at www.organovo.com.